Status:
COMPLETED
Postpartum Screening of Type 2 Diabetes
Lead Sponsor:
Université de Sherbrooke
Collaborating Sponsors:
The Lawson Foundation
Conditions:
Type 2 Diabetes
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Gestational diabetes mellitus (GDM) complicates 5 to 30 % of pregnancies. GDM is defined as hyperglycemia with onset or first recognition during pregnancy. Because it is a forerunner of type 2 diabete...
Eligibility Criteria
Inclusion
- Women aged between 18 and 45 years;
- Having a positive diagnosis of gestational diabetes mellitus (IADPSG criteria);
- Treated with diet or insulin;
- Have given birth to a child at term; gestational age \> 37 weeks;
- Have been followed during her pregnancy by a physician who delivers in CHUS;
- Have signed the consent form.
Exclusion
- History of glucose intolerance or diabetes before the pregnancy;
- Have presented another obstetrical pathology during the pregnancy;
- Severe gestational high blood pressure with proteinuria;
- Delayed intrauterine development syndrome;
- Pregnancy with more than a foetus;
- Drug addiction;
- Had complications during the delivery such as:
- Moderate to severe postpartum bleeding;
- Surgery in postpartum (curettage, hysterectomy, etc.).
Key Trial Info
Start Date :
April 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT01869608
Start Date
April 1 2014
End Date
December 31 2018
Last Update
May 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Center Étienne-Le Bel of the Sherbrooke University Hospital
Sherbrooke, Quebec, Canada, J1H 5N4